Global Liposomal Amikacin Market Growth 2023-2029

March 2023 | 75 pages | ID: G897C214DAB8EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Amikacin is an antibiotic used for a number of bacterial infections

LPI (LP Information)' newest research report, the “Liposomal Amikacin Industry Forecast” looks at past sales and reviews total world Liposomal Amikacin sales in 2022, providing a comprehensive analysis by region and market sector of projected Liposomal Amikacin sales for 2023 through 2029. With Liposomal Amikacin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Liposomal Amikacin industry.

This Insight Report provides a comprehensive analysis of the global Liposomal Amikacin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Liposomal Amikacin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Liposomal Amikacin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Liposomal Amikacin and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Liposomal Amikacin.

The global Liposomal Amikacin market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Liposomal Amikacin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Liposomal Amikacin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Liposomal Amikacin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Liposomal Amikacin players cover Insmed. etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Liposomal Amikacin market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• Brands
• Generic

Segmentation by application

• Hospital
• Drugs Store

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Insmed

Key Questions Addressed in this Report

What is the 10-year outlook for the global Liposomal Amikacin market?

What factors are driving Liposomal Amikacin market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Liposomal Amikacin market opportunities vary by end market size?

How does Liposomal Amikacin break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Liposomal Amikacin Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Liposomal Amikacin by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Liposomal Amikacin by Country/Region, 2018, 2022 & 2029
2.2 Liposomal Amikacin Segment by Type
  2.2.1 Brands
  2.2.2 Generic
2.3 Liposomal Amikacin Sales by Type
  2.3.1 Global Liposomal Amikacin Sales Market Share by Type (2018-2023)
  2.3.2 Global Liposomal Amikacin Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Liposomal Amikacin Sale Price by Type (2018-2023)
2.4 Liposomal Amikacin Segment by Application
  2.4.1 Hospital
  2.4.2 Drugs Store
2.5 Liposomal Amikacin Sales by Application
  2.5.1 Global Liposomal Amikacin Sale Market Share by Application (2018-2023)
  2.5.2 Global Liposomal Amikacin Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Liposomal Amikacin Sale Price by Application (2018-2023)

3 GLOBAL LIPOSOMAL AMIKACIN BY COMPANY

3.1 Global Liposomal Amikacin Breakdown Data by Company
  3.1.1 Global Liposomal Amikacin Annual Sales by Company (2018-2023)
  3.1.2 Global Liposomal Amikacin Sales Market Share by Company (2018-2023)
3.2 Global Liposomal Amikacin Annual Revenue by Company (2018-2023)
  3.2.1 Global Liposomal Amikacin Revenue by Company (2018-2023)
  3.2.2 Global Liposomal Amikacin Revenue Market Share by Company (2018-2023)
3.3 Global Liposomal Amikacin Sale Price by Company
3.4 Key Manufacturers Liposomal Amikacin Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Liposomal Amikacin Product Location Distribution
  3.4.2 Players Liposomal Amikacin Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR LIPOSOMAL AMIKACIN BY GEOGRAPHIC REGION

4.1 World Historic Liposomal Amikacin Market Size by Geographic Region (2018-2023)
  4.1.1 Global Liposomal Amikacin Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Liposomal Amikacin Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Liposomal Amikacin Market Size by Country/Region (2018-2023)
  4.2.1 Global Liposomal Amikacin Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Liposomal Amikacin Annual Revenue by Country/Region (2018-2023)
4.3 Americas Liposomal Amikacin Sales Growth
4.4 APAC Liposomal Amikacin Sales Growth
4.5 Europe Liposomal Amikacin Sales Growth
4.6 Middle East & Africa Liposomal Amikacin Sales Growth

5 AMERICAS

5.1 Americas Liposomal Amikacin Sales by Country
  5.1.1 Americas Liposomal Amikacin Sales by Country (2018-2023)
  5.1.2 Americas Liposomal Amikacin Revenue by Country (2018-2023)
5.2 Americas Liposomal Amikacin Sales by Type
5.3 Americas Liposomal Amikacin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Liposomal Amikacin Sales by Region
  6.1.1 APAC Liposomal Amikacin Sales by Region (2018-2023)
  6.1.2 APAC Liposomal Amikacin Revenue by Region (2018-2023)
6.2 APAC Liposomal Amikacin Sales by Type
6.3 APAC Liposomal Amikacin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Liposomal Amikacin by Country
  7.1.1 Europe Liposomal Amikacin Sales by Country (2018-2023)
  7.1.2 Europe Liposomal Amikacin Revenue by Country (2018-2023)
7.2 Europe Liposomal Amikacin Sales by Type
7.3 Europe Liposomal Amikacin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Liposomal Amikacin by Country
  8.1.1 Middle East & Africa Liposomal Amikacin Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Liposomal Amikacin Revenue by Country (2018-2023)
8.2 Middle East & Africa Liposomal Amikacin Sales by Type
8.3 Middle East & Africa Liposomal Amikacin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Liposomal Amikacin
10.3 Manufacturing Process Analysis of Liposomal Amikacin
10.4 Industry Chain Structure of Liposomal Amikacin

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Liposomal Amikacin Distributors
11.3 Liposomal Amikacin Customer

12 WORLD FORECAST REVIEW FOR LIPOSOMAL AMIKACIN BY GEOGRAPHIC REGION

12.1 Global Liposomal Amikacin Market Size Forecast by Region
  12.1.1 Global Liposomal Amikacin Forecast by Region (2024-2029)
  12.1.2 Global Liposomal Amikacin Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Liposomal Amikacin Forecast by Type
12.7 Global Liposomal Amikacin Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Insmed
  13.1.1 Insmed Company Information
  13.1.2 Insmed Liposomal Amikacin Product Portfolios and Specifications
  13.1.3 Insmed Liposomal Amikacin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Insmed Main Business Overview
  13.1.5 Insmed Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Liposomal Amikacin Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Liposomal Amikacin Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Brands
Table 4. Major Players of Generic
Table 5. Global Liposomal Amikacin Sales by Type (2018-2023) & (K Units)
Table 6. Global Liposomal Amikacin Sales Market Share by Type (2018-2023)
Table 7. Global Liposomal Amikacin Revenue by Type (2018-2023) & ($ million)
Table 8. Global Liposomal Amikacin Revenue Market Share by Type (2018-2023)
Table 9. Global Liposomal Amikacin Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Liposomal Amikacin Sales by Application (2018-2023) & (K Units)
Table 11. Global Liposomal Amikacin Sales Market Share by Application (2018-2023)
Table 12. Global Liposomal Amikacin Revenue by Application (2018-2023)
Table 13. Global Liposomal Amikacin Revenue Market Share by Application (2018-2023)
Table 14. Global Liposomal Amikacin Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Liposomal Amikacin Sales by Company (2018-2023) & (K Units)
Table 16. Global Liposomal Amikacin Sales Market Share by Company (2018-2023)
Table 17. Global Liposomal Amikacin Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Liposomal Amikacin Revenue Market Share by Company (2018-2023)
Table 19. Global Liposomal Amikacin Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Liposomal Amikacin Producing Area Distribution and Sales Area
Table 21. Players Liposomal Amikacin Products Offered
Table 22. Liposomal Amikacin Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Liposomal Amikacin Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Liposomal Amikacin Sales Market Share Geographic Region (2018-2023)
Table 27. Global Liposomal Amikacin Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Liposomal Amikacin Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Liposomal Amikacin Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Liposomal Amikacin Sales Market Share by Country/Region (2018-2023)
Table 31. Global Liposomal Amikacin Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Liposomal Amikacin Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Liposomal Amikacin Sales by Country (2018-2023) & (K Units)
Table 34. Americas Liposomal Amikacin Sales Market Share by Country (2018-2023)
Table 35. Americas Liposomal Amikacin Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Liposomal Amikacin Revenue Market Share by Country (2018-2023)
Table 37. Americas Liposomal Amikacin Sales by Type (2018-2023) & (K Units)
Table 38. Americas Liposomal Amikacin Sales by Application (2018-2023) & (K Units)
Table 39. APAC Liposomal Amikacin Sales by Region (2018-2023) & (K Units)
Table 40. APAC Liposomal Amikacin Sales Market Share by Region (2018-2023)
Table 41. APAC Liposomal Amikacin Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Liposomal Amikacin Revenue Market Share by Region (2018-2023)
Table 43. APAC Liposomal Amikacin Sales by Type (2018-2023) & (K Units)
Table 44. APAC Liposomal Amikacin Sales by Application (2018-2023) & (K Units)
Table 45. Europe Liposomal Amikacin Sales by Country (2018-2023) & (K Units)
Table 46. Europe Liposomal Amikacin Sales Market Share by Country (2018-2023)
Table 47. Europe Liposomal Amikacin Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Liposomal Amikacin Revenue Market Share by Country (2018-2023)
Table 49. Europe Liposomal Amikacin Sales by Type (2018-2023) & (K Units)
Table 50. Europe Liposomal Amikacin Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Liposomal Amikacin Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Liposomal Amikacin Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Liposomal Amikacin Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Liposomal Amikacin Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Liposomal Amikacin Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Liposomal Amikacin Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Liposomal Amikacin
Table 58. Key Market Challenges & Risks of Liposomal Amikacin
Table 59. Key Industry Trends of Liposomal Amikacin
Table 60. Liposomal Amikacin Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Liposomal Amikacin Distributors List
Table 63. Liposomal Amikacin Customer List
Table 64. Global Liposomal Amikacin Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Liposomal Amikacin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Liposomal Amikacin Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Liposomal Amikacin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Liposomal Amikacin Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Liposomal Amikacin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Liposomal Amikacin Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Liposomal Amikacin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Liposomal Amikacin Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Liposomal Amikacin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Liposomal Amikacin Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Liposomal Amikacin Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Liposomal Amikacin Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Liposomal Amikacin Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Insmed Basic Information, Liposomal Amikacin Manufacturing Base, Sales Area and Its Competitors
Table 79. Insmed Liposomal Amikacin Product Portfolios and Specifications
Table 80. Insmed Liposomal Amikacin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Insmed Main Business
Table 82. Insmed Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Liposomal Amikacin
Figure 2. Liposomal Amikacin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Liposomal Amikacin Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Liposomal Amikacin Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Liposomal Amikacin Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Brands
Figure 10. Product Picture of Generic
Figure 11. Global Liposomal Amikacin Sales Market Share by Type in 2022
Figure 12. Global Liposomal Amikacin Revenue Market Share by Type (2018-2023)
Figure 13. Liposomal Amikacin Consumed in Hospital
Figure 14. Global Liposomal Amikacin Market: Hospital (2018-2023) & (K Units)
Figure 15. Liposomal Amikacin Consumed in Drugs Store
Figure 16. Global Liposomal Amikacin Market: Drugs Store (2018-2023) & (K Units)
Figure 17. Global Liposomal Amikacin Sales Market Share by Application (2022)
Figure 18. Global Liposomal Amikacin Revenue Market Share by Application in 2022
Figure 19. Liposomal Amikacin Sales Market by Company in 2022 (K Units)
Figure 20. Global Liposomal Amikacin Sales Market Share by Company in 2022
Figure 21. Liposomal Amikacin Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Liposomal Amikacin Revenue Market Share by Company in 2022
Figure 23. Global Liposomal Amikacin Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Liposomal Amikacin Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Liposomal Amikacin Sales 2018-2023 (K Units)
Figure 26. Americas Liposomal Amikacin Revenue 2018-2023 ($ Millions)
Figure 27. APAC Liposomal Amikacin Sales 2018-2023 (K Units)
Figure 28. APAC Liposomal Amikacin Revenue 2018-2023 ($ Millions)
Figure 29. Europe Liposomal Amikacin Sales 2018-2023 (K Units)
Figure 30. Europe Liposomal Amikacin Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Liposomal Amikacin Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Liposomal Amikacin Revenue 2018-2023 ($ Millions)
Figure 33. Americas Liposomal Amikacin Sales Market Share by Country in 2022
Figure 34. Americas Liposomal Amikacin Revenue Market Share by Country in 2022
Figure 35. Americas Liposomal Amikacin Sales Market Share by Type (2018-2023)
Figure 36. Americas Liposomal Amikacin Sales Market Share by Application (2018-2023)
Figure 37. United States Liposomal Amikacin Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Liposomal Amikacin Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Liposomal Amikacin Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Liposomal Amikacin Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Liposomal Amikacin Sales Market Share by Region in 2022
Figure 42. APAC Liposomal Amikacin Revenue Market Share by Regions in 2022
Figure 43. APAC Liposomal Amikacin Sales Market Share by Type (2018-2023)
Figure 44. APAC Liposomal Amikacin Sales Market Share by Application (2018-2023)
Figure 45. China Liposomal Amikacin Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Liposomal Amikacin Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Liposomal Amikacin Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Liposomal Amikacin Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Liposomal Amikacin Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Liposomal Amikacin Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Liposomal Amikacin Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Liposomal Amikacin Sales Market Share by Country in 2022
Figure 53. Europe Liposomal Amikacin Revenue Market Share by Country in 2022
Figure 54. Europe Liposomal Amikacin Sales Market Share by Type (2018-2023)
Figure 55. Europe Liposomal Amikacin Sales Market Share by Application (2018-2023)
Figure 56. Germany Liposomal Amikacin Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Liposomal Amikacin Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Liposomal Amikacin Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Liposomal Amikacin Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Liposomal Amikacin Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Liposomal Amikacin Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Liposomal Amikacin Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Liposomal Amikacin Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Liposomal Amikacin Sales Market Share by Application (2018-2023)
Figure 65. Egypt Liposomal Amikacin Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Liposomal Amikacin Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Liposomal Amikacin Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Liposomal Amikacin Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Liposomal Amikacin Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Liposomal Amikacin in 2022
Figure 71. Manufacturing Process Analysis of Liposomal Amikacin
Figure 72. Industry Chain Structure of Liposomal Amikacin
Figure 73. Channels of Distribution
Figure 74. Global Liposomal Amikacin Sales Market Forecast by Region (2024-2029)
Figure 75. Global Liposomal Amikacin Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Liposomal Amikacin Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Liposomal Amikacin Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Liposomal Amikacin Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Liposomal Amikacin Revenue Market Share Forecast by Application (2024-2029)